Pliant Therapeutics, Inc.
PLRX· Nasdaq
Released Nov 7, 2024, after the close
10-Q filed Nov 7, 2024, 38 days after period end · 0001746473-24-000171
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $1.48M | $1.61M |
| Net Income | -$57.76M | -$41.49M | -$30.62M | -$27.05M |
| EPS Diluted |
Pliant Therapeutics, Inc. · CIK 1746473 · Engraved from SEC EDGAR
| -$0.95 |
| -$0.70 |
| -$0.65 |
| -$0.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.